Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT06352281 · RECRUITING
Trial details
- NCT number
- NCT06352281
- Sponsor
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-01-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.